T, F., M, S., C, K., M, N., M, Y., M, I., . . . A, H. (2009). CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole. European Journal of Clinical Pharmacology, 65(7), 693-699.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
T, Furuta, et al. "CYP2C19 Genotype Is Associated with Symptomatic Recurrence of GERD During Maintenance Therapy with Low-dose Lansoprazole."
European Journal of Clinical Pharmacology 65, no. 7 (2009): 693-699.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
T, Furuta, et al. "CYP2C19 Genotype Is Associated with Symptomatic Recurrence of GERD During Maintenance Therapy with Low-dose Lansoprazole."
European Journal of Clinical Pharmacology, vol. 65, no. 7, 2009, pp. 693-699.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.